HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Cynthia Wu Selected Research
Cynthia Wu Research Topics
Disease
16
Hemorrhage
01/2024 - 04/2009
16
Venous Thromboembolism
10/2021 - 04/2009
6
Neoplasms (Cancer)
12/2021 - 02/2010
5
Venous Thrombosis (Deep-Vein Thrombosis)
01/2022 - 02/2010
4
Thrombosis (Thrombus)
01/2021 - 03/2015
4
Pulmonary Embolism
11/2020 - 05/2017
3
COVID-19
10/2021 - 07/2021
3
Atrial Fibrillation
11/2019 - 01/2015
2
Hemophilia A (Haemophilia)
01/2023 - 01/2021
2
Thrombocytopenia (Thrombopenia)
08/2021 - 12/2016
2
Ischemic Stroke
01/2021 - 11/2019
2
Stroke (Strokes)
01/2021 - 01/2015
2
Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
01/2020 - 01/2020
2
Embolism (Embolus)
11/2019 - 01/2015
2
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
11/2016 - 01/2016
1
Seizures (Absence Seizure)
02/2024
1
Epilepsy (Aura)
02/2024
1
Colorectal Neoplasms (Colorectal Cancer)
10/2021
1
Critical Illness (Critically Ill)
07/2021
1
Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
01/2021
1
Pain (Aches)
11/2020
1
Transient Ischemic Attack
11/2019
1
Thromboembolism
11/2019
1
Hypotension (Low Blood Pressure)
01/2018
1
Chronic Renal Insufficiency
10/2017
1
Frailty
10/2017
1
Hypertension (High Blood Pressure)
01/2017
1
Cardiovascular Diseases (Cardiovascular Disease)
01/2017
1
Upper Extremity Deep Vein Thrombosis
12/2016
1
Leukemia
12/2016
1
Heart Diseases (Heart Disease)
11/2016
1
Urinary Tract Infections (Urinary Tract Infection)
08/2012
Drug/Important Bio-Agent (IBA)
19
Anticoagulants
IBA
01/2022 - 04/2009
5
Warfarin (Coumadin)
FDA Link
Generic
01/2021 - 08/2013
4
fibrin fragment D (D-dimer)
IBA
10/2021 - 04/2009
4
Rivaroxaban
IBA
11/2020 - 11/2019
3
Heparin (Liquaemin)
FDA Link
Generic
10/2021 - 11/2019
3
Vitamin K
FDA Link
09/2019 - 09/2014
2
Blood Coagulation Factors (Coagulation Factor)
IBA
01/2024 - 01/2021
2
Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)
IBA
01/2021 - 09/2019
1
Bevacizumab (Avastin)
FDA Link
10/2021
1
Vaccines
IBA
08/2021
1
Inosine Triphosphate (ITP)
IBA
01/2021
1
Tissue Plasminogen Activator (Alteplase)
FDA Link
01/2021
1
Dabigatran
FDA Link
11/2019
1
apixaban
IBA
11/2019
1
Creatinine
IBA
11/2019
1
Oral Contraceptives
IBA
11/2017
1
Manganese
IBA
01/2017
1
Anthracyclines
IBA
11/2016
1
Granulocyte Colony-Stimulating Factor (G-CSF)
IBA
11/2016
1
Cytarabine (Cytosar-U)
FDA Link
Generic
11/2016
1
fludarabine
IBA
11/2016
1
vinyltriethoxysilane (VTES)
IBA
05/2016
1
insulin receptor-related receptor (IRR)
IBA
02/2015
1
Aspirin (Acetylsalicylic Acid)
FDA Link
Generic
02/2015
1
Endothelial Protein C Receptor
IBA
11/2013
1
Protein C
IBA
11/2013
1
Amyloid (Amyloid Fibrils)
IBA
08/2012
Therapy/Procedure
14
Therapeutics
02/2024 - 04/2009
3
Drug Therapy (Chemotherapy)
08/2017 - 01/2016
2
Critical Care (Surgical Intensive Care)
01/2023 - 02/2010
2
Length of Stay
05/2018 - 08/2017
2
Ambulatory Care (Outpatient Care)
08/2017 - 08/2015
1
Artificial Respiration (Mechanical Ventilation)
10/2021
1
Thrombectomy
01/2021
1
Sympathectomy (Sympathectomies)
01/2018
1
Contraindications
05/2017
1
Vena Cava Filters (Inferior Vena Cava Filter)
05/2017
1
Central Venous Catheters
12/2016
1
Catheters
12/2016
1
Secondary Prevention
02/2015
1
Duration of Therapy
04/2009